Relapsed or Refractory Acute Myeloid Leukemia (AML) Clinical Trials in Suzhou, Jiangsu
3 recruitingSuzhou, Jiangsu, China
Showing 1–3 of 3 trials
Recruiting
Not Applicable
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
Relapsed or Refractory Acute Myeloid Leukemia (AML)MDS (Myelodysplastic Syndrome)
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT07500753
Recruiting
Phase 2
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tarapeutics Science Inc.18 enrolled1 locationNCT05241093
Recruiting
Phase 2
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tarapeutics Science Inc.15 enrolled1 locationNCT05241106